RACHEL CROWLEY: Open Payments
NPI 1487801114 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,051 in 112 payments from 24 companies in 2025. Trend: 2023 $1,266 · 2024 $1,746 · 2025 $2,051
Food & beverage: $2,051
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $260 |
| Axsome Therapeutics, Inc. | 12 | $220 |
| Novo Nordisk Inc | 13 | $205 |
| AstraZeneca Pharmaceuticals LP | 3 | $181 |
| Eisai Inc. | 6 | $172 |
| Lilly USA, LLC | 10 | $165 |
| Insulet Corporation | 2 | $106 |
| Astellas Pharma US Inc | 3 | $87 |
| Phathom Pharmaceuticals, Inc. | 8 | $79 |
| PFIZER INC. | 4 | $72 |
Products named: Leqembi, AIRSUPRA, Auvelity, QULIPTA, JARDIANCE, Omnipod, UBRELVY, MOUNJARO.
Industry payments across KY — which companies pay providers there.
